Related Experiment Video
Updated: Jun 27, 2025

A Knowledge Graph Approach to Elucidate the Role of Organellar Pathways in Disease via Biomedical Reports
Published on: October 13, 2023
Elucidating the semantics-topology trade-off for knowledge inference-based pharmacological discovery
Daniel N Sosa1, Georgiana Neculae2, Julien Fauqueur2
1Stanford University, Department of Biomedical Data Science, Stanford, CA, USA.
Artificial intelligence (AI) in drug discovery can be biased by network structure. New methods are needed to leverage biomedical knowledge graphs for accurate pharmacological innovation.
Area of Science:
- Biomedical Informatics
- Artificial Intelligence
- Pharmacological Discovery
Background:
- Artificial intelligence (AI) offers significant potential for accelerating pharmacological discovery by synthesizing vast amounts of biomedical knowledge.
- Knowledge graphs representing interactions between drugs, diseases, genes, and proteins are crucial for machine learning (ML)-based discovery methods like link prediction.
- Existing predictive models are often biased by network topology, relying on high-degree nodes rather than nuanced biological understanding.
Purpose of the Study:
- To investigate the confounding effect of network topology on the semantic understanding of biological relations within knowledge graphs.
- To evaluate the impact of topological bias on the performance of drug repurposing applications.
- To identify the need for novel knowledge representation and inference methods for effective pharmacological innovation.
Main Methods:
- Development of an experimental pipeline to perform semantic and topological perturbations on biomedical knowledge graphs.
- Assessment of drug repurposing performance degradation when biological semantics are ablated under varying topological conditions.
- Quantification of the increase in performance drop due to topological bias mitigation.
Main Results:
- Ablating meaningful semantics led to a performance drop in drug repurposing.
- This performance drop increased by 21% and 38% in two different networks when topological bias was mitigated.
- Topological biases significantly confound the interpretation of biological relations in knowledge graphs.
Conclusions:
- Current methods for knowledge representation and inference in biomedical knowledge graphs are insufficient for fully utilizing biological semantics.
- Addressing topological biases is critical for improving the accuracy and reliability of AI-driven pharmacological discovery.
- New approaches are necessary to develop robust methods for knowledge representation and inference to advance pharmacological innovation.
Related Concept Videos
Drug Discovery: Overview
Agonism and Antagonism: Quantification
To quantify these effects, researchers use a dose-response curve, which provides valuable information about the potency and efficacy of a drug. Potency refers to...
Structure-Activity Relationships and Drug Design
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
Pharmacokinetic Models: Overview
There are three primary types of models: empirical, compartment, and physiological. Empirical models, with minimal...
Pharmacodynamics: Overview and Principles
Most drugs' effects result from their interactions with drug receptors or targets within the body. These interactions trigger specific responses at the cellular or systemic level. Drug receptors can be found on the surfaces of cells or...
Nonlinear Pharmacokinetics: Bioavailability and Protein-Drug Binding
To quantify the extent of bioavailability, pharmacologists often use a parameter called .

